Table 2.

Correlation between serum ALT and FA and Cer in psoriatic patients (n = 85). Significant correlations are marked as: *p < 0.05

Fatty acid	r	P-value	Ceramide	r	P-value
Myristic (14:0)	0.17	0.116	Cer myristic (C14:0)	–0.02	0.847
Palmitic (16:0)	0.16	0.147	Cer. palmitic (C16:0)	0.03	0.768
Palmitoleic (16:1n-7)	0.15	0.173	Cer palmitoleic (C16:1)	0.19	0.086
Stearic (18:0)	0.18	0.102	Cer stearic (C18:0)	0.05	0.659
Oleic (18:1n9c)	0.12	0.270	Cer oleic (C18:1n9)	0.17	0.117
Linoleic (18:2n-6)	–0.07	0.516	Cer linoleic (C18:2)	–0.03	0.788
Arachidic (20:0)	–0.04	0.748	Cer arachidic (C20:0)	–0.02	0.865
α-Linolenic (18:3n-3)	0.01	0.919	Cer α-Linolenic (C18:3)	–0.04	0.738
Behenic (22:0)	–0.14	0.206	Cer behenic (C22:0)	0.20	0.065
Arachidonic (20:4n-6)	–0.00	0.993	Cer arachidonic (C20:4)	–0.03	0.813
Lignoceric (24:0)	–0.11	0.329	Cer lignoceric (C24:0)	0.22	0.045*
Eicosapentaenoic (20:5n-3)	0.01	0.923	Cer eicosapentaenoic (C20:5)	0.13	0.231
Nervonic (24:1n-9)	–0.13	0.235	Cer nervonic (C24:1)	0.06	0.613
Docosahexaenoic (22:6n-3)	–0.07	0.549	Cer docosahexaenoic (C22:6)	0.20	0.069
Total FA	0.12	0.270	Total Cer	0.12	0.280
n-3 PUFA	–0.04	0.693	Sphingosine-1-phosphate	–0.02	0.877
n-6 PUFA	–0.08	0.477
n-6/n-3 ratio	0.00	0.994
%SFA	0.27	0.013*
%MUFA	0.10	0.346
%PUFA	–0.19	0.078
SFA/UFA	0.27	0.014*